Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by InvestingWiseon Apr 12, 2019 8:14am
66 Views
Post# 29617198

RE:RE:RE:Question if anyone can answer!!

RE:RE:RE:Question if anyone can answer!!However, as your cost will be 0,90$ -- and not anymore 0,09$ -- there are a few steps to go until this stock moves up from 0,35 to a dollar... In fact, it's much more harder to climb from 30 to 90 cents than from 0,035 to 0,09. But I'm confident that ADK might succeed within 1-2 years.
Also, don't forget that several firms selling 25 to 40 million $ a year are only valued 15 to 50 cents, and Bombardier with 17 billion $ is stalling around 2,70$...
Diagnos is not yet seen as a promising AI company, still perceived by too many investors and analysts as a small mining speculative firm... Thus its very low value...
Bullboard Posts